Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTc030230742Suspended
Open-label, single-arm trial of platelet-rich plasma in Rhizarthrosis. Primary endpoint: Safety of regenerative medical technology using frozen PRP cell-processing products. Started Oct 2024; status: suspended.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTc030230742.